Anagrelide

CAS : 68475-42-3

Ref. 3D-FA168205

Informations sur le produit

• Nom: Anagrelide
• Synonymes: 11-6-1, 6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one, 6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one, 68475-42-3, Bl 4162A, Xagrid, imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-, imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-5,10-dihydro-

Description

Anagrelide is a molecule that inhibits the JAK2 kinase and has been shown to inhibit the process of angiogenesis. It is used in the treatment of myeloproliferative disorders, such as polycythemia vera, thrombocythemia, or leukemia. The effects of anagrelide on the cardiovascular system have been studied in detail. Anagrelide has also been shown to be effective in experimental models for human diseases such as cancer and arthritis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 256.09 g/mol
• Formule: C₁₀H₇Cl₂N₃O
• Degré de pureté: Min. 95%
• Couleur/Forme: White/Off-White Solid
• InChI: InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)
• Code InChI: InChIKey=OTBXOEAOVRKTNQ-UHFFFAOYSA-N
• SMILES: O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1